Ceftobiprole medocaril

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Ceftobiprole medocaril is the parenteral prodrug of Ceftobiprole. Ceftobiprole is a broad-spectrum cephalosporin with activity against Methicillin-resistant staphylococcus aureus (MRSA).

Ceftobiprole medocaril is the parenteral prodrug of Ceftobiprole. Ceftobiprole is a broad-spectrum cephalosporin with activity against Methicillin-resistant staphylococcus aureus (MRSA).(In Vivo):Ceftobiprole medocaril (10, 40, 160 mg/kg; single dose; sc) has T 1/2 s from 20 min to 31 min, as the dose rose from 40 mg/kg to 160 mg/kg. The AUC/dose values for the escalating single doses ranges from 0.585 to 1.33, and the C max /dose values decreases from 1.08 to 0.90 in neutropenic thigh-infected mice .

BAL5788

GPCR/G Protein

Antibacterial

——

——

——

376653-43-9

690.7

C26H26N8O11S2

>98% (HPLC)

——

CC(O1)=C(COC(N(CC2)C[C@@H]2N(CC/C2=C\C(CS[C@@H]3[C@@H]4NC(/C(/c5nsc(N)n5)=N\O)=O)=C(C(O)=O)N3C4=O)C2=O)=O)OC1=O

——

(-20℃)

With Ice Pack

≥ 2 years